Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net Income	$ 4,724	$ 6,365
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	1,200	1,150
Depreciation and amortization	1,246	948
Net amortization on securities	1,685	2,987
Increase in cash surrender value of bank owned life insurance	(141)
Amortization of core deposit intangible	154	31
Share based compensation expense	593	662
Net securities losses (gains)	1,128	(648)
Increase in accrued interest receivable	(777)	(132)
Increase in other assets	(5,811)	(70)
Increase in accrued expenses and other liabilities	4,820	4,359
Net cash provided by operating activities	8,821	15,652
Cash flows from investing activities:
Purchases of securities available for sale	(208,973)	(210,801)
Purchases of securities, restricted	(266,592)	(19,873)
Purchases of securities held to maturity	(30,936)	(32,781)
Proceeds from sales of securities available for sale	234,749	75,165
Redemption of securities, restricted	265,536	16,852
Maturities, calls and principal payments of securities available for sale	36,510	97,170
Maturities, calls and principal payments of securities held to maturity	26,763	57,420
Net increase in loans	(101,313)	(102,956)
Proceeds from sales of other real estate owned, net	2,242
Purchase of premises and equipment	(2,321)	(2,748)
Net cash acquired in business combination	2,926
Net cash used in investing activities	(41,409)	(122,552)
Cash flows from financing activities:
Net increase in deposits	42,119	45,785
Net increase (decrease) in federal funds purchased	6,000	(9,000)
Net increase in FHLB advances	8,804	60,000
Repayment of acquired unsecured debt	(1,450)
Net increase (decrease) in repurchase agreements	22	(1,089)
Net proceeds from issuance of common stock	310	3,004
Net proceeds from exercise of stock options	7
Repurchase of surrendered stock from vesting of restricted stock awards	(147)	(149)
Excess tax benefit (expense) from share based compensation	30	(9)
Cash dividends paid	(5,287)	(2,069)
Other, net	(192)
Net cash provided in financing activities	50,216	96,473
Net decrease in cash and cash equivalents	17,628	(10,427)
Cash and cash equivalents at beginning of period	45,573	51,249
Cash and cash equivalents at end of period	63,201	40,822
Cash paid for:
Interest	3,656	3,592
Income tax	883	2,937
Noncash investing and financing activities:
Securities which settled in the subsequent period	5,372	6,726
Transfers from portfolio loans to OREO	577
Acquisition of noncash assets and liabilities:
Fair value of assets acquired	207,121
Fair value of liabilities assumed	$ 212,547